LB6. Oral Lefamulin Is Safe and Effective in the Treatment of Adults With Community-Acquired Bacterial Pneumonia (CABP): Results of Lefamulin Evaluation Against Pneumonia (LEAP 2) Study

BACKGROUND: Lefamulin, a first in class pleuromutilin, is being developed as an IV and oral formulation for treating CABP. The second of 2 phase 3 Lefamulin Evaluation Against Pneumonia studies, LEAP 2 (NCT02813694; EudraCT 2015-004782-92) evaluating an oral 5-day regimen, is presented here. LEAP 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, Elizabeth, Goldberg, Lisa, Das, Anita, Moran, Gregory J, Sandrock, Christian, Gasink, Leanne B, Spera, Patricia, Sweeney, Carolyn, Paukner, Susanne, Wicha, Wolfgang W, Schranz, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253245/
http://dx.doi.org/10.1093/ofid/ofy229.2180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253245/
http://dx.doi.org/10.1093/ofid/ofy229.2180

Ejemplares similares